Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differentially expressed immune response genes in COVID-19 patients based on disease severity

29 Mar 2021

Abstract excerpt

BACKGROUND: Dysregulated immune responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are thought to underlie the progression of coronavirus disease 2019 (COVID-19). We sought to further characterize host antiviral and cytokine gene expression in COVID-19 patients based on illness severity. METHODS: In this case-control study, we retrospectively analyzed 46 recovered COVID-19 patients and 24...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Long-Term Effects of COVID-19
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33780352
DOI: 10.18632/aging.202877

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differentially expressed immune response genes in COVID-19 patients based on disease severityPMID 33780352Read ↗

Impaired type I interferon activity and exacerbated inflammatory responses in severe Covid-19 patientsSemantic proximity Read ↗

Type I, II, and III interferon signatures correspond to COVID-19 disease severitySemantic proximity Read ↗

Cell type-specific immune dysregulation in severely ill COVID-19 patientsSemantic proximity Read ↗

Upregulated type I interferon responses in asymptomatic COVID-19 infection are associated with improved clinical outcomeSemantic proximity Read ↗

Blood transcriptome responses in patients correlate with severity of COVID-19 diseaseSemantic proximity Read ↗

Transcriptomic Signature Differences Between SARS-CoV-2 and Influenza Virus Infected PatientsSemantic proximity Read ↗

Identification of key molecules in COVID-19 patients significantly correlated with clinical outcomes by analyzing transcriptomic dataSemantic proximity Read ↗

Integrated Transcriptomic Analysis Reveals Distinct Immune Response Signatures and Prognostic Biomarkers in SARS-CoV-2 InfectionSemantic proximity Read ↗

Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanismSemantic proximity Read ↗

Dysregulation of Immune Response in Patients with COVID-19 in Wuhan, ChinaSemantic proximity Read ↗

Two distinct immunopathological profiles in autopsy lungs of COVID-19Semantic proximity Read ↗

Antiviral innate immunity is diminished in the upper respiratory tract of severe COVID-19 patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.